News
ARQT ▼ -10.5% - Arcutis Biotherapeutics, Inc.
ARQT ▼ -10.5% - Arcutis Biotherapeutics, Inc.
$ARQT reported Q3 2026 EPS of $0.06, missing the $0.17 estimate by 64.7%. Revenue of $143.9M beat the $142.4M estimate by 1.1%.
04-NOV-2026 04:06 PM ET
Share this post
More filings for $ARQT
ARQT ▼ -7.5% - Arcutis Biotherapeutics, Inc.Nov 4, 2026ARQT ▼ -0.2% - Arcutis Biotherapeutics, Inc.Oct 28, 2026ARQT ▼ -0.4% - Arcutis Biotherapeutics, Inc.Oct 27, 2026ARQT ▼ -3.0% - Arcutis Biotherapeutics, Inc.Oct 21, 2026ARQT ▲ +0.9% - Arcutis Biotherapeutics, Inc.Oct 9, 2026ARQT ▲ +1.8% - Arcutis Biotherapeutics, Inc.Oct 9, 2026
View full $ARQT filing history →💬 Comments
Loading comments…
Leave a comment